{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL5166&min-dateTabled=2015-10-13&min-ddpModified=2015-02-06T18%3A50%3A44.583Z&min-AnswerDate=2015-06-18", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=HL5166&min-dateTabled=2015-10-13&min-ddpModified=2015-02-06T18%3A50%3A44.583Z&min-AnswerDate=2015-06-18", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL5166&min-dateTabled=2015-10-13&min-ddpModified=2015-02-06T18%3A50%3A44.583Z&min-AnswerDate=2015-06-18&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL5166&_page=0&min-dateTabled=2015-10-13&min-ddpModified=2015-02-06T18%3A50%3A44.583Z&min-AnswerDate=2015-06-18", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL5166&min-dateTabled=2015-10-13&min-ddpModified=2015-02-06T18%3A50%3A44.583Z&min-AnswerDate=2015-06-18", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL5166&min-dateTabled=2015-10-13&min-ddpModified=2015-02-06T18%3A50%3A44.583Z&min-AnswerDate=2015-06-18", "items" : [{"_about" : "http://data.parliament.uk/resources/1581434", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1581434/answer", "answerText" : {"_value" : "

The Department has received materials from pharmaceutical industry Trade Associations and from individual companies about the impact of changes to the voluntary and statutory schemes for branded medicines prices.<\/p>

<\/p>

These include responses to the assessments made by the Department in the draft impact assessment that accompanies our recent consultation on increased rates in the statutory scheme. We will be considering this evidence over the coming weeks and will publish our response alongside the final impact assessment.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-02-09", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-02-09T15:18:29.267Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-01-26", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS: Drugs"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government, following their response to the consultation on the extent of the impact on inward investment of higher payments under the statutory scheme to control the costs of branded medicines, what assessment they have made of the sensitivity analysis used to assess that impact; and whether they are proposing changes to that analysis.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1732", "label" : {"_value" : "Biography information for Lord Warner"} } , "tablingMemberPrinted" : [{"_value" : "Lord Warner"} ], "uin" : "HL5166"} , {"_about" : "http://data.parliament.uk/resources/1400561", "AnsweringBody" : [{"_value" : "Foreign, Commonwealth and Development Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1400561/answer", "answerText" : {"_value" : "

The UK takes very seriously talk of secession and other threats to undo the progress of the last twenty-six years in Bosnia and Herzegovina (BiH), and remains committed to helping BiH maintain lasting peace and stability. The EU stabilisation force, EUFOR, plays a vital role in safeguarding peace and security. Although the UK no longer participates in EUFOR following our withdrawal from the European Union, we liaise closely with Commander EUFOR and his team. We also support the NATO HQ in Sarajevo including though the secondment of UK staff officers, who are building the capacity of the BiH Armed Forces. At the NATO Foreign Ministers' Meeting in Riga, the Foreign Secretary called on Allies to enhance NATO's engagement on BiH. The UK will continue to support BiH in implementing domestic reforms and tackling challenges to peace and security.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4062", "label" : {"_value" : "Biography information for Lord Goldsmith of Richmond Park"} } , "answeringMemberPrinted" : {"_value" : "Lord Goldsmith of Richmond Park"} , "dateOfAnswer" : {"_value" : "2022-01-13", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-01-13T11:50:34.353Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2022-01-06", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Bosnia and Herzegovina: Politics and Government"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what steps they are taking to help support the (1) police, and (2) security, forces in Bosnia-Herzegovina given separatist threats.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4282", "label" : {"_value" : "Biography information for Lord Bourne of Aberystwyth"} } , "tablingMemberPrinted" : [{"_value" : "Lord Bourne of Aberystwyth"} ], "uin" : "HL5166"} , {"_about" : "http://data.parliament.uk/resources/1200321", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1200321/answer", "answerText" : {"_value" : "

As of April 2019, UK Research and Innovation (UKRI) investment in AI relevant research and innovation activities totals over £1bn. This breaks down as follows:<\/p>

<\/p>